Maternal diet, rather than obesity itself, has a main influence on milk triacylglycerol profile in dietary obese rats.


Journal

Biochimica et biophysica acta. Molecular and cell biology of lipids
ISSN: 1879-2618
Titre abrégé: Biochim Biophys Acta Mol Cell Biol Lipids
Pays: Netherlands
ID NLM: 101731727

Informations de publication

Date de publication:
02 2020
Historique:
received: 14 05 2019
revised: 24 10 2019
accepted: 25 10 2019
pubmed: 5 11 2019
medline: 13 5 2020
entrez: 4 11 2019
Statut: ppublish

Résumé

Triacylglycerols (TG) in milk derive from different sources, and their composition may be influenced by both maternal diet and obesity. We used two rat models to ascertain potential changes in TG composition in milk associated to maternal intake of an obesogenic diet during lactation and to distinguish them from the effects attributable to maternal adiposity. Milk samples were obtained from dams fed a cafeteria diet during lactation (CAF) and from dams made obese by cafeteria diet feeding, with dietary normalization before gestation (PCaf). Levels of specific TG species in milk collected at different time points of lactation were determined by shotgun lipidomics. CAF and PCaf dams presented a greater adiposity than their respective controls. The principal component analysis of TG peaks showed a clear separation between milk from CAF dams and milk from control and Pcaf dams, already evident at 5 days of lactation. Milk from CAF dams was enriched with TG species with greater number of carbons and double bonds and reduced in TG with lower number of carbons. TG composition of milk from Pcaf dams was similar to controls, although specific differences were observed at day 5 of lactation. Thus, the intake of a cafeteria diet during lactation, rather than maternal adiposity, alters milk composition. This effect is avoided with dietary normalization before gestation, although the remaining fat reserves may also influence TG composition at initial stages of lactation. Therefore, normalization of maternal diet prior to pregnancy should be considered as a strategy for achieving optimal milk composition.

Identifiants

pubmed: 31678620
pii: S1388-1981(19)30207-0
doi: 10.1016/j.bbalip.2019.158556
pii:
doi:

Substances chimiques

Triglycerides 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

158556

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Auteurs

C A Pomar (CA)

Laboratory of Molecular Biology, Nutrition and Biotechnology (Nutrigenomics and Obesity), Palma de Mallorca, Spain; University of the Balearic Islands and CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Palma de Mallorca, Spain; Instituto de Investigación Sanitaria Illes Balears, Palma de Mallorca, Spain.

O Kuda (O)

Department of Adipose Tissue Biology, Institute of Physiology of the Czech Academy of Sciences, Prague, Czech Republic.

J Kopecky (J)

Department of Adipose Tissue Biology, Institute of Physiology of the Czech Academy of Sciences, Prague, Czech Republic.

M Rombaldova (M)

Department of Adipose Tissue Biology, Institute of Physiology of the Czech Academy of Sciences, Prague, Czech Republic.

H Castro (H)

Laboratory of Molecular Biology, Nutrition and Biotechnology (Nutrigenomics and Obesity), Palma de Mallorca, Spain; Universidad Autónoma de Nuevo León, Facultad de Salud Pública y Nutrición, Nuevo León, Mexico.

C Picó (C)

Laboratory of Molecular Biology, Nutrition and Biotechnology (Nutrigenomics and Obesity), Palma de Mallorca, Spain; University of the Balearic Islands and CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Palma de Mallorca, Spain; Instituto de Investigación Sanitaria Illes Balears, Palma de Mallorca, Spain.

J Sánchez (J)

Laboratory of Molecular Biology, Nutrition and Biotechnology (Nutrigenomics and Obesity), Palma de Mallorca, Spain; University of the Balearic Islands and CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Palma de Mallorca, Spain; Instituto de Investigación Sanitaria Illes Balears, Palma de Mallorca, Spain. Electronic address: joana.sanchez@uib.es.

A Palou (A)

Laboratory of Molecular Biology, Nutrition and Biotechnology (Nutrigenomics and Obesity), Palma de Mallorca, Spain; University of the Balearic Islands and CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Palma de Mallorca, Spain; Instituto de Investigación Sanitaria Illes Balears, Palma de Mallorca, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH